Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection (clinicaltrials.gov) - Mar 10, 2022 - P3 | N=250 | Not yet recruiting | Sponsor: Valenta Pharm JSC
New P3 trial • Cough • Infectious Disease • Respiratory Diseases
|